Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
72
XERS Quote, Financials, Valuation and Earnings
Last price:
$7.22
Seasonality move
:
-6.43%
Day range:
$7.17 - $7.32
52-week range:
$3.14 - $10.08
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.33x
P/B ratio:
--
Volume:
781K
Avg. volume:
2.1M
1-year change:
107.78%
Market cap:
$1.2B
Revenue:
$203.1M
EPS (TTM):
-$0.10
Earnings Data
Next earnings date for XERS
Mar 05
2026
Most recent earnings per share
$0.00
Missed by $0.00
(Nov 6/2025)
Consensus Estimate
$0.01
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
XERS Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/05/2026 | Q4 | $81.4M | -- | -- | $0.05 | -- |
| 11/06/2025 | Q3 | $74.2M | $74.4M | $0.00 | $0.01 | -$0.00 |
| 08/07/2025 | Q2 | $64.6M | $71.5M | -$0.01 | -$0.03 | $0.02 |
| 05/08/2025 | Q1 | $57.6M | $60.1M | -$0.06 | -$0.04 | -$0.02 |
| 03/06/2025 | Q4 | $58.5M | $60.1M | -$0.03 | -$0.02 | -$0.01 |
| 11/08/2024 | Q3 | $51.4M | $54.3M | -$0.11 | -$0.08 | -$0.03 |
| 08/08/2024 | Q2 | $45.8M | $48.1M | -$0.10 | -$0.09 | -$0.01 |
| 05/09/2024 | Q1 | $41.8M | $40.6M | -$0.14 | -$0.11 | -$0.03 |
| 03/06/2024 | Q4 | $43.6M | $44.4M | -$0.09 | -$0.09 | -$0.00 |
| 11/09/2023 | Q3 | -- | -- | -$0.09 | -$0.11 | $0.02 |
| 08/08/2023 | Q2 | -- | -- | -$0.14 | -$0.11 | -$0.03 |
| 05/09/2023 | Q1 | -- | -- | -$0.12 | -$0.15 | $0.03 |
| 03/08/2023 | Q4 | -- | -- | -$0.10 | -$0.15 | $0.05 |
| 11/09/2022 | Q3 | -- | -- | -$0.16 | -$0.16 | -$0.01 |
| 08/10/2022 | Q2 | -- | -- | -$0.19 | -$0.22 | $0.03 |
| 05/11/2022 | Q1 | -- | -- | -$0.25 | -- | -- |
| 03/10/2022 | Q4 | -- | -- | -$0.42 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.39 | -- | -- |
| 08/05/2021 | Q2 | -- | -- | -$0.41 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$0.30 | -- | -- |
| 03/09/2021 | Q4 | -- | -- | -$0.41 | -- | -- |
| 11/09/2020 | Q3 | -- | -- | -$0.35 | -- | -- |
| 08/10/2020 | Q2 | -- | -- | -$0.63 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$0.89 | -- | -- |
| 03/11/2020 | Q4 | -- | -- | -$1.23 | -- | -- |
| 11/07/2019 | Q3 | -- | -- | -$1.22 | -- | -- |
| 08/06/2019 | Q2 | -- | -- | -$1.28 | -- | -- |
| 05/09/2019 | Q1 | -- | -- | -$1.07 | -- | -- |
| 03/06/2019 | Q4 | -- | -- | -$0.98 | -- | -- |
| 11/07/2018 | Q3 | -- | -- | -$0.71 | -- | -- |
| 08/13/2018 | Q2 | -- | -- | -$3.07 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$5.49 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$4.22 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$3.47 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$2.41 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$2.14 | -- | -- |
Xeris Biopharma Holdings, Inc. Earnings Questions
-
How Much did Xeris Biopharma Holdings, Inc. Generate in Revenue Last Quarter?
Xeris Biopharma Holdings, Inc. reported $74.4M worth of top line sales in its most recent quarter.
-
Did Xeris Biopharma Holdings, Inc. Beat Earnings Last Quarter?
Xeris Biopharma Holdings, Inc. announced earnings per share of $0.00 which represents a miss of analyst forecast a $0.01 per share.
-
Is Xeris Biopharma Holdings, Inc. Profitable?
Xeris Biopharma Holdings, Inc. reported $60.7M that represents $0.34 per share over the last quarter.
-
What is the Analyst Consensus for Xeris Biopharma Holdings, Inc. EPS Next Year?
Xeris Biopharma Holdings, Inc.'s earnings are forecast to decrease from -$0.37 per share to -$0.25 per share next year representing a decrease of -89.29%.
-
When is Xeris Biopharma Holdings, Inc.'s Earnings Date?
Xeris Biopharma Holdings, Inc.'s next earnings date is March 5, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
